Epilepsy Pipeline Highlights - H2 2016 Update - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Epilepsy Pipeline Highlights - 2016 Update" drug pipelines to their offering.

Epilepsy Pipeline Highlights - 2016 Update, provides most up-to-date information on key pipeline products in the global Epilepsy market. It covers emerging therapies for Epilepsy in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Clinical Trial Stages:

The report provides Epilepsy pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Drug Mechanism Classes:

The report provides Epilepsy pipeline products by their dominant mechanism of action. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.

Company:

The report provides Epilepsy pipeline products by the company.

Short-term Launch Highlights:

Find out which Epilepsy pipeline products will be launched in the US and Ex-US till 2019.

Key Topics Covered:

1. Epilepsy Pipeline by Stages

2. Epilepsy Pipeline by Drug Class

3. Epilepsy Pipeline by Company

4. Epilepsy Phase 3 Clinical Trial Insights

5. Epilepsy Phase 2 Clinical Trial Insights

6. Epilepsy Phase 1 Clinical Trial Insights

7. Epilepsy Preclinical Research Insights

8. Epilepsy Discovery Stage Insights

9. Appendix

For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/t5ztfz/epilepsy_pipeline

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Central Nervous System Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Central Nervous System Drugs